Compound Detail
CHEMBL766
CILASTATIN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL766 |
| Name | CILASTATIN |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | DHSUYTOATWAVLW-WFVMDLQDSA-N |
| Therapeutic | ✓ Yes |
1
Targets
9
Activities
2
Assay Types
5
PK Parameters
20
Publications
4
Known Names
9
Indications
1
Mechanisms
Molecular Properties
358.5
MW (Da)
1.43
ALogP
5
HBA
4
HBD
129.7
PSA (Ų)
0.32
QED
0
Ro5 Violations
11
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1985 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Renal dipeptidase inhibitor | INHIBITOR | Dipeptidase 1 | ✓ | ✓ |
Indications
Bacterial Infections Pneumonia, Bacterial Pneumonia, Ventilator-Associated Pyelonephritis Urinary Tract Infections Hematologic Neoplasms Infections Sepsis Osteomyelitis
Activity Summary
Ki 5 meas. best 6.96
IC50 4 meas.
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Dipeptidase 1 CHEMBL2626 | Ki | 6.96 | 6.7867 | 110.0 | 3 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 2.3 | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.3 | mL.min-1.kg-1 | Homo sapiens |
| Fu | 0.6 | - | Homo sapiens |
| MRT | 1.1 | hr | Homo sapiens |
| T1/2 | 0.86 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Dipeptidase 1 | Ki | = | 110.0 | nM | 6.96 | Inhibitory activity against beta-lactamase renal dipeptidase | 3495664 |
| Dipeptidase 1 | Ki | = | 190.0 | nM | 6.72 | Inhibitory activity against beta-lactamase renal dipeptidase | 3495664 |
| Dipeptidase 1 | Ki | = | 210.0 | nM | 6.68 | Inhibitory activity against beta-lactamase renal dipeptidase | 3495664 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL5303304 | U2OS | 8 |
| - | 10.6019/CHEMBL5303304 | HEK-293T | 5 |
| - | 10.6019/CHEMBL5303304 | Fibroblast | 5 |
| 18426954 | 10.1124/dmd.108.020479 | ADMET | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 3495664 | 10.1021/jm00389a018 | Dipeptidase 1 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Thromboxane A2 receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Prostaglandin G/H synthase 1 | 2 |
| 28628823 | 10.1016/j.ejmech.2017.06.005 | Mycobacterium tuberculosis | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M1 | 2 |
| 14978359 | 10.1254/jphs.94.197 | Organic anion transporter 3 | 2 |
| 14978359 | 10.1254/jphs.94.197 | Solute carrier family 22 member 6 | 2 |
| 19445515 | 10.1021/jm900403j | Homo sapiens | 2 |
| 18834112 | 10.1021/jm800656v | Amine oxidase [flavin-containing] B | 2 |
| 18834112 | 10.1021/jm800656v | Amine oxidase [flavin-containing] A | 2 |
| - | 10.6019/CHEMBL5308504 | Bromodomain-containing protein 4 | 1 |
Data from ChEMBL 36 via Core Engine